Delivery Order SPE2DB22D2206-SPE2DB25FEA74

Award Date 11/1/24
Potential Completion Date 11/25/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,978.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a period of performance through April 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of pharmaceutical products, including the medication TESTOPEL 75 MG PELLETS 100S, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $7,956.18 and a completion date of June 27, 2024. It is a firm fixed-price delivery order contract without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,978.09 firm fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 100S, a prescription pharmaceutical product. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various federal agencies, with a focus on serving the Department of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,978.09 contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a period of performance through August 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $7,956.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a prescription medication. The delivery order has a completion date of October 1, 2024 and is a Firm Fixed Price contract. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded numerous...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP20Y, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,978.09, is for the delivery of 4564821333 TESTOPEL 75 MG PELLETS 100S and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a ceiling value of $12,346.74 and a performance period ending on February 11, 2025. It is a firm-fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a firm fixed price of $11,934.27 and runs through September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical...
This federal contract award is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to Amerisourcebergen Drug Corp's Corporate Office division, has a ceiling value of $7,956.18 and a completion date of September 24, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 units of TESTOPEL 75 MG PELLETS. The order, valued at $3,978.09, is to be completed by January 26, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received multiple awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEA74
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,978.09 fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a completion date of November 25, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/31/25, 9:02 AM